MV
Medicxi Ventures
Venture CapitalActiveMedicxi is a life sciences-focused investment firm.
30
Investments
7
Exits
$2B
AUM
23.3%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Medicxi Ventures.
Investment Thesis & Strategy
Medicxi Ventures invests in life sciences companies across various stages, seeking to support innovation in the healthcare sector.
Investment Activity
Deals per year over the last 5 years
2
20140
20155
20163
20172
2018Portfolio Companies
Selected investments from their portfolio of 30 companies
I
Inositec
Biotech · Series A, 2018
V
Venturepharm
Biotech · Series A, 2018
O
Obsidian Therapeutics
Biotech · Series A, 2017
M
Minoryx Therapeutics
Biotech · Series B, 2017
i
iTeos Therapeutics
Biotech · Series B, 2017
A
Asceneuron
Biotech · Series B, 2016
A
Adrenomed
Biotech · Series B, 2016
A
AM-Pharma
Biotech · Series C+, 2016
A
Alector
Biotech · Series B, 2016
M
Morphic Therapeutic
Biotech · Series B, 2016
V
Vaximm
Biotech · Series B, 2014
G
GenSight Biologics
Biotech · Series C+, 2014
Notable Exits
CompanyTypeYearValue / Acquirer
Inception TherapeuticsAcquisition2023—
AM-PharmaAcquisition2023$1.16B
AM PharmaAcquisition2023$1.16B
VelosBioAcquisition2020$2.75B
Impact BiomedicinesAcquisition2018$1.1B
ObsEvaIPO2017—
GenSight BiologicsIPO2016—
Frequently Asked Questions
Medicxi Ventures focuses on Series A, Series B, Series C+ stage investments.